Lifeward (NASDAQ:LFWD – Get Free Report) and Stryker (NYSE:SYK – Get Free Report) are both healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, profitability, earnings, risk, valuation, dividends and analyst recommendations.
Insider and Institutional Ownership
26.8% of Lifeward shares are held by institutional investors. Comparatively, 77.1% of Stryker shares are held by institutional investors. 1.5% of Lifeward shares are held by insiders. Comparatively, 4.6% of Stryker shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
Profitability
This table compares Lifeward and Stryker’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Lifeward | -123.66% | -243.14% | -97.39% |
| Stryker | 14.43% | 23.63% | 11.39% |
Analyst Ratings
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Lifeward | 1 | 1 | 1 | 0 | 2.00 |
| Stryker | 0 | 5 | 17 | 1 | 2.83 |
Lifeward currently has a consensus target price of $10.00, indicating a potential upside of 29.79%. Stryker has a consensus target price of $386.28, indicating a potential upside of 11.95%. Given Lifeward’s higher probable upside, equities research analysts clearly believe Lifeward is more favorable than Stryker.
Risk & Volatility
Lifeward has a beta of 0.38, indicating that its share price is 62% less volatile than the S&P 500. Comparatively, Stryker has a beta of 0.76, indicating that its share price is 24% less volatile than the S&P 500.
Valuation and Earnings
This table compares Lifeward and Stryker”s revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Lifeward | $22.03 million | 0.99 | -$19.91 million | ($19.66) | -0.39 |
| Stryker | $25.12 billion | 5.27 | $3.25 billion | $9.65 | 35.76 |
Stryker has higher revenue and earnings than Lifeward. Lifeward is trading at a lower price-to-earnings ratio than Stryker, indicating that it is currently the more affordable of the two stocks.
Summary
Stryker beats Lifeward on 14 of the 15 factors compared between the two stocks.
About Lifeward
ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke. The company markets and sells its products directly to institutions and individuals, as well as through third-party distributors. The company was formerly known as Argo Medical Technologies Ltd. ReWalk Robotics Ltd. was incorporated in 2001 and is headquartered in Yokneam Illit, Israel.
About Stryker
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, clinical communication and workflow solutions, and other medical device products that are used in various medical specialties, as well as patient and caregiver safety technologies. This segment also provides neurosurgical, neurovascular and craniomaxillofacial implant products, which include products used for minimally invasive endovascular procedures; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.
Receive News & Ratings for Lifeward Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lifeward and related companies with MarketBeat.com's FREE daily email newsletter.
